BIOMERICA INC Income Statement
BMRA|14 years of annual SEC 10-K data (FY2012-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 14 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
N/A
FY2025
Gross Profit
N/A
FY2025
Operating Income
N/A
FY2025
Net Income
N/A
FY2025
Revenue has declined at a 1.6% compound annual rate over the past 12 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -6.26 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 1/9 criteria passed
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | $5.3M | $5.4M | $5.3M | $18.9M | $7.2M | $5.2M | $5.2M | $5.6M | $5.8M | $5.1M | $5.0M | $5.1M | $6.5M |
| Cost of Revenue | - | $4.8M | $4.8M | $4.9M | $15.9M | $6.8M | $3.9M | $3.9M | $3.8M | $3.8M | $3.6M | $3.4M | $3.5M | $4.0M |
| Gross Profit | - | $498.0K | $611.0K | $446.0K | $3.0M | $366.3K | $1.3M | $1.3M | $1.8M | $2.0M | $1.5M | $1.5M | $1.7M | $2.4M |
| SG&A Expense | - | $4.6M | $5.5M | $6.1M | $5.7M | $5.7M | $2.0M | $2.0M | $1.8M | $1.8M | $1.6M | $1.5M | $1.5M | $1.5M |
| R&D Expense | - | $1.0M | $1.5M | $1.6M | $1.8M | $2.2M | $1.7M | $1.7M | $1.4M | $1.1M | $780.3K | $733.6K | $589.9K | $459.1K |
| Operating Income | - | -$5.1M | -$6.4M | -$7.2M | -$4.5M | -$7.5M | -$2.4M | -$2.4M | -$1.5M | -$954.6K | -$827.0K | -$670.6K | -$446.6K | $514.0K |
| Interest Expense | - | - | - | - | $367 | $367 | $47 | $47 | $37 | $282 | $167 | $142 | $142 | $302 |
| Income Tax | - | $1.0K | $42.0K | $51.0K | $24.0K | $13.1K | $24.2K | $24.2K | $31.8K | $703.8K | $703.8K | -$315.0K | -$210.8K | -$12.5K |
| Net Income | - | -$5.0M | -$6.0M | -$7.1M | -$4.5M | -$7.4M | -$2.4M | -$2.4M | -$1.5M | -$908.6K | -$1.5M | -$331.4K | -$215.7K | $537.0K |
| EPS (Basic) | -$2.84 | -$0.50 | -$0.36 | -$0.62 | -$0.23 | -$0.26 | -$0.17 | -$0.11 | -$0.20 | -$0.04 | -$0.03 | $0.08 | $0.08 | $0.02 |
| EPS (Diluted) | -$2.84 | -$0.50 | -$0.36 | -$0.62 | -$0.23 | -$0.26 | -$0.17 | -$0.11 | -$0.20 | -$0.04 | -$0.03 | $0.07 | $0.08 | $0.02 |
| Shares Outstanding | 2.1M | 16.8M | 12.9M | 12.3M | 11.7M | 9.7M | 8.9M | 8.5M | 8.2M | 7.6M | 7.5M | 7.3M | 7.0M | 6.9M |
| Gross Margin | - | 9.4% | 11.3% | 8.3% | 15.8% | 5.1% | 24.8% | 24.8% | 31.5% | 34.9% | 29.6% | 31.1% | 32.6% | 37.5% |
| Operating Margin | - | -96.7% | -117.6% | -135.3% | -24.0% | -104.2% | -46.4% | -46.4% | -26.6% | -16.5% | -16.1% | -13.5% | -8.7% | 7.9% |
| Profit Margin | - | -93.6% | -110.4% | -133.7% | -24.0% | -103.4% | -46.0% | -46.0% | -26.3% | -15.7% | -29.2% | -6.7% | -4.2% | 8.3% |